Core Viewpoint - Southbound funds have significantly increased their holdings in MicroPort Medical (00853.HK), indicating strong investor interest and confidence in the company [1]. Group 1: Southbound Fund Activity - On October 31, southbound funds increased their holdings by 1.4855 million shares, marking a 0.17% change [2]. - Over the past five trading days, there have been four days of net increases, totaling 4.09 million shares [1]. - In the last 20 trading days, there were 15 days of net increases, amounting to 51.2419 million shares [1]. - As of now, southbound funds hold 886 million shares of MicroPort Medical, which represents 46.31% of the company's total issued ordinary shares [1]. Group 2: Company Overview - MicroPort Medical is primarily engaged in the sales, production, research, and development of medical devices [2]. - The company operates through eight divisions, including cardiovascular intervention, orthopedic medical devices, cardiac rhythm management, and surgical robotics [2]. - Key products include implantable devices, spinal instruments, and surgical robots, among others [2].

Core Viewpoint - MicroPort Medical (00853) reported the performance of its subsidiary, HeartCare Medical (688016.SH), for the first three quarters of 2025, indicating a mixed financial outcome with revenue growth but a decline in net profit [1] Financial Performance - Revenue for the first three quarters was approximately 1.015 billion yuan, representing a year-on-year increase of 4.66% [1] - Net profit attributable to shareholders was around 429 million yuan, showing a year-on-year decrease of 22.46% [1] - Basic earnings per share stood at 3.54 yuan [1]

Group 1 - The core point of the article is that MicroPort Medical (00853) reported the performance of its subsidiary, HeartCare Medical (688016.SH), for the first three quarters of 2025, showing a revenue of approximately 1.015 billion yuan, which represents a year-on-year growth of 4.66% [1] - The net profit attributable to shareholders of the listed company is approximately 429 million yuan, reflecting a year-on-year decrease of 22.46% [1] - The basic earnings per share are reported at 3.54 yuan [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 微創醫療科學有限公司* （於開曼群島註冊成立的有限公司） （股份代號：00853） 海外監管公告 承董事會命 微創醫療科學有限公司* 常兆華博士 主席 中國上海，二零二五年十月二十九日 於本公告日期，本公司之執行董事為常兆華博士；本公司之非執行董事為谷峰博士、門慶兵博士及 孫維琴女士；及本公司之獨立非執行董事為周嘉鴻先生、劉國恩博士及邵春陽先生。 * 僅供識別 本海外監管公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第13.10B條刊 發。 請參閱隨附上海微創心脈醫療科技（集團）股份有限公司（「心脈醫療科技」）於上海證券交易所科創板 （「科創板」）刊發之公告（「該公告」），內容有關其二零二五年第三季度報告。 心脈醫療科技為一家於科創板上市之公司。於本公告日期，本集團持有心脈醫療科技已發行股本約 40.32%及其業績於本公司財務報表合併入賬。 於聯交所網站登載該公告，僅為向香港投 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 本公司股東及潛在投資者於買賣本公司證券時務請審慎行事。 承董事會命 微創醫療科學有限公司* （於開曼群島註冊成立的有限公司） （股份代號：00853） 上海微創心脈醫療科技（集團）股份有限公司 截至二零二五年九月三十日止九個月未經審核財務資料 以下所載為上海微創心脈醫療科技（集團）股份有限公司（「心脈醫療科技」）截至二零二五年九月三十日 止九個月的未經審核財務資料。本集團持有心脈醫療科技40.32%的股權，其業績綜合入賬至本公司 財務報表。心脈醫療科技的股份在上海證券交易所科創板上市。 | | 截至 | 截至 | | | --- | --- | --- | --- | | | 二零二五年 | 二零二四年 | | | | 九月三十日止 | 九月三十日止 | | | | 九個月 | 九個月 | 變動 | | | 人民幣千元 | 人民幣千元 | 百分比 | | 收入 | 1,014,780.04 | 969,5 ...

開曼群島 公司法（經修訂） 股份有限公司 微創醫療科學有限公司 之 經第五次修訂及重訂的組織章程大綱及細則 （經於二零二五年十月二十二日通過的特別決議案採納） – 1 – 開曼群島 公司法（經修訂） 股份有限公司 微創醫療科學有限公司 之 經第五次修訂及重訂的組織章程大綱 公司法（經修訂） 股份有限公司 微創醫療科學有限公司 之 經第五次修訂及重訂的組織章程大綱 （經於二零二五年十月二十二日通過的特別決議案採納） – 3 – 1 本公司的名稱為微創醫療科學有限公司。 2 本公司的註冊辦事處設於PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, Maples Corporate Services Limited的辦事處，或董事會不時決定的其 他地點。 3 本公司的成立宗旨並無限制，包括但不限於以下各項： (a) 以投資公司及投資控股公司的形式經營業務，以及收購及持有由任何性質及在任 何地點成立或經營業務的任何公司、企業或實體發行或擔保的任何種類的股份、 股票、債權股份、債券、按揭、債務及證券、由任何政府、主權執政者、專責 機構、信託 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 1 附註： 承董事會命 微創醫療科學有限公司* 主席 微創醫療科學有限公司* （於開曼群島註冊成立的有限公司） （股份代號：00853) 於二零二五年十月二十二日舉行之股東特別大會的表決結果 微創醫療科學有限公司（「本公司」）之董事會（分別為「董事」及「董事會」）欣然公佈，刊載於日期為二零 二五年九月三十日之本公司股東特別大會（「股東特別大會」）通告內的提呈決議案，已於二零二五年 十月二十二日舉行之股東特別大會上，以按股數投票表決方式獲本公司普通股之持有人（分別為「股 份」及「股東」）正式通過。投票表決結果如下： | | 特別決議案 | 票數(%) | | | --- | --- | --- | --- | | | | 贊成 | 反對 | | 1. | 「動議批准及採納經第五次修訂及重訂的本公司組織 | 473,216,694 | 0 | | | 章程大綱及組織章程細則（「新章程細則」）（其副本已 | ...

Group 1 - The core point of the news is that southbound funds have significantly increased their holdings in MicroPort Scientific Corporation (00853.HK), with a total net increase of 13.18 million shares over the last five trading days and 47.15 million shares over the last twenty trading days [1][2] - As of October 17, 2025, southbound funds hold 876 million shares of MicroPort, accounting for 45.8% of the company's total issued ordinary shares [1][2] - The daily changes in shareholding show fluctuations, with a notable increase of 4.95 million shares on October 16, 2025, and a decrease of 519,300 shares on October 15, 2025 [2] Group 2 - MicroPort Scientific Corporation specializes in the manufacturing and sales of medical devices, with divisions focused on orthopedic, cardiovascular, neuro-interventional, surgical, robotic, cardiac rhythm management, and heart valve products [2]

Core Insights - The top three companies with the highest short positions as of October 3 are COSCO Shipping Holdings (01919), Ganfeng Lithium (01772), and ZTE Corporation (00763), with short ratios of 15.66%, 15.25%, and 15.16% respectively [1][2] - Ganfeng Lithium (01772) saw the largest absolute increase in short positions, rising by 1.20%, followed by Minmetals Resources (01208) with an increase of 0.96%, and Yuexiu Transport Infrastructure (01052) with an increase of 0.76% [1][2] - The companies with the largest decreases in short positions include GCL-Poly Energy (03800), which decreased by 3.16%, followed by Dongfang Electric (01072) with a decrease of 2.03%, and Jinxin Fertility (01951) with a decrease of 0.76% [1][3] Summary of Short Positions - **Top 10 Companies by Short Ratio** - COSCO Shipping Holdings (01919): 15.66% (from 437 million shares to 451 million shares) - Ganfeng Lithium (01772): 15.25% (from 62.30 million shares to 67.64 million shares) - ZTE Corporation (00763): 15.16% (from 113 million shares to 115 million shares) - CATL (03750): 13.83% (from 21.12 million shares to 21.57 million shares) - Vanke (02202): 12.63% (from 268 million shares to 279 million shares) - Ping An Insurance (02318): 12.59% (from 959 million shares to 938 million shares) - Zijin Mining (02899): 12.58% (from 750 million shares to 754 million shares) - MicroPort Medical (00853): 11.10% (from 213 million shares to 212 million shares) - Hansoh Pharmaceutical (01276): 11.01% (from 28.01 million shares to 28.43 million shares) - Fuyao Glass (06865): 10.85% (from 49.22 million shares to 47.94 million shares) [2] - **Top 10 Companies with Increased Short Positions** - Ganfeng Lithium (01772): Increased by 1.20% (from 14.05% to 15.25%) - Minmetals Resources (01208): Increased by 0.96% (from 1.96% to 2.93%) - Yuexiu Transport Infrastructure (01052): Increased by 0.76% (from 1.08% to 1.84%) - Jinli Permanent Magnet (06680): Increased by 0.66% (from 7.76% to 8.42%) - China Civil Aviation Information Network (00696): Increased by 0.58% (from 6.63% to 7.21%) [2] - **Top 10 Companies with Decreased Short Positions** - GCL-Poly Energy (03800): Decreased by 3.16% (from 11.76% to 8.59%) - Dongfang Electric (01072): Decreased by 2.03% (from 6.78% to 4.75%) - Jinxin Fertility (01951): Decreased by 0.76% (from 10.61% to 9.85%) - Yangtze Optical Fibre and Cable (06869): Decreased by 0.75% (from 7.03% to 6.28%) - Shanghai Electric (02727): Decreased by 0.72% (from 2.25% to 1.52%) [3][4]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 微創醫療科學有限公司 呈交日期: 2025年10月8日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00853 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.00001 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 5,000,000,000 | USD | | 0.00001 | USD | | 50,000 | 本月底法定/註冊股本總 ...